fbpx

Marsha Ames lived in Topeka Kansas with her family of six, a happy homemaker married to a steel shed company executive. Their lovely single family residence was on a corner of a street in suburban Topeka that could have been the setting for a Hallmark channel movie. Life was good; the future bright.

Then she went to her doctor for a routine exam and they dianosed her with stage 3 lymph node cancer. She was given six months to live, tops.

The shock wave was instantaneous. Her husband located the very best doctor he could find, at the best facilities. They told her there was little beyond conventional chemotherapy they could do. He pressed, and found a doctor in their research department who was experimenting with a new form of proton laser that had show some hope in a few cases. They asked the cost.

Although President Trump’s new law allowing experimental techniques was in effect, insurance companies were not compelled nor required to cover experimental techniques. They had to find over $500,000 somehow, some way.

They considered a home loan, but they had just moved into their home that Spring, so there was no equity in it yet. They could go for a personal loan, but without an asset to back it no bank would extend a loan of that size even with his excellent credit.

He had over $1M in stocks and bonds, but this was the family’s nest egg, designed to help cover the kids future college costs. Sacrificing their future for his wife was something neither he nor his wife could accept doing.

His stock portfolio was diverse and of a solid quality, with bonds, stocks and mutual funds equally distributed. But over the past three years of a booming economy and stock market, it had increased in value almost 50 percent – which meant a huge capital gains tax hit if he sold them.

Desperate, he went online and eventually found A. B. Nicholas Securities Finance, the specialists in securiites portfolio lending programs. We obtained a loan for $750,000 at 3.5%, interest-only required, and delivered it in a matter of days. All without selling a single share or foregoing their children’s inheritance, giving them unlimited time to repay as it is a revolving line of credit.

Six months later amazed doctors declared Marsha cancer-free. Several remarked that they’d never seen a case of complete remission in a person with advanced lymph node cancer. Yet, there it was, the result of a brave new therapy and a loan from A. B. Nicholas that literally saved a life…

Apply today for your LeverageLine!

Share on facebook
Facebook
Share on google
Google+
Share on twitter
Twitter
Share on linkedin
LinkedIn
Related Posts

Three New Cannabis Stocks Now Eligible for Loans/Credit Lines

A. B. Nicholas announces ability to leverage several leading cannabis stocks for a competitive-rate credit line.  As of October, 2021, A. B. Nicholas is happy to be one of the few companies able to deliver credit lines and loans against several cannabis stocks. These can get a loan-to-value as high as 60% depending on volatility and volume of trading.  Our licensed, public-institution U. S. lending network has already provided credit

Where There’s a Will, There’s a Way: The LeverageLine Stock Loan Advantage

Here at A. B. Nicholas, we’re ready for anything.  Even the client who comes to us with bankruptcies, foreclosures, or credit issues from the past. That’s because of the type of licensed, major-institution stock loan lenders that we have in the network we have built over a decade.  When a client brings in a case with a portfolio of, say, $100,000, but has had a recent foreclosure that prevents him

Is It Possible to Build a Better Structure Than a Conventional Margin Loan? Yes.

They say necessity is the mother of invention. So few were surprised when back in 2009, in the midst of the Great Recession, that way, a small franchise consulting firm like ours would find itself in difficult circumstances given that conventional lending windows had been closing left and right. After all individuals who were looking into buying franchises couldn’t very well continue without a robust lending environment and even those

Join Our Weekly Newsletter

We do not sell, communicate or divulge your information to any third-parties.